Alanine, arginine, aspartic acid, cysteine/cystine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine monohydrate, methionine, ornithine hydrochloride, phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine, valine; sod... - paediatric investigation plan

alanine
arginine
aspartic acid
cysteine
cystine
glutamic acid
glycine
histidine
isoleucine
leucine
lysine monohydrate
methionine
ornithine hydrochloride
phenylalanine
proline
serine
taurine
threonine
tryptophan
tyrosine
valine
sodium chloride
potassium acetate
magnesium acetate tetrahydrate
calcium chloride
sodium glycerophosphate
glucose
soya bean oil
olive oil
PIPHuman

Key facts

Active Substance
  • alanine
  • arginine
  • aspartic acid
  • cysteine
  • cystine
  • glutamic acid
  • glycine
  • histidine
  • isoleucine
  • leucine
  • lysine monohydrate
  • methionine
  • ornithine hydrochloride
  • phenylalanine
  • proline
  • serine
  • taurine
  • threonine
  • tryptophan
  • tyrosine
  • valine
  • sodium chloride
  • potassium acetate
  • magnesium acetate tetrahydrate
  • calcium chloride
  • sodium glycerophosphate
  • glucose
  • soya bean oil
  • olive oil
Therapeutic area
Nutrition
Decision number
P/191/2009
PIP number
Alanine, arginine, aspartic acid, cysteine/cystine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine monohydrate, methionine, ornithine hydrochloride, phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine, valine; sod...
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Parenteral nutrition
Route(s) of administration
Intravenous use
Contact for public enquiries

Baxter World Trade SPRL

E-mail: jacek_bedkowski@baxter.com
Country: Belgium
Phone: +32 26501850
Fax: +32 26501679

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date
Compliance procedure number
EMEA-C-000112-PIP01-07-M01
Compliance opinion date
Compliance outcome
Positive

Decision

Share this page